Veterinary Medicine Information website

Nobilis REO+IB+G+ND vakcina A.U.V.

Authorised
  • Avian reovirus, strain 2408, Inactivated
  • Avian reovirus, strain 1733, Inactivated
  • Infectious bursal disease virus, Inactivated
  • Newcastle disease virus, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis REO+IB+G+ND vakcina A.U.V.
Active substance:
  • Avian reovirus, strain 2408, Inactivated
  • Avian reovirus, strain 1733, Inactivated
  • Infectious bursal disease virus, Inactivated
  • Newcastle disease virus, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Target species:
  • Chicken (hen)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Avian reovirus, strain 2408, Inactivated
    7.40
    log2 enzyme-linked immunosorbent assay unit(s)
    /
    1.00
    unit(s)/dose
  • Avian reovirus, strain 1733, Inactivated
    7.40
    log2 enzyme-linked immunosorbent assay unit(s)
    /
    1.00
    unit(s)/dose
  • Infectious bursal disease virus, Inactivated
    14.50
    log2 virus neutralising unit(s)
    /
    1.00
    unit(s)/dose
  • Newcastle disease virus, Inactivated
    50.00
    50% Protective Dose
    /
    1.00
    unit(s)/dose
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    6.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (hen)
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA16
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: